Navigation Links
Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
Date:10/23/2013

ALISO VIEJO, Calif., Oct. 23, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will host a live webcast in conjunction with its Investor Relations Day on Tuesday, October 29, 2013 at 12:30 p.m. ET in New York City.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

To view and listen to the webcast please visit our website at http://ir.avanir.com. Visitors will also be able to view and listen to an archive copy of the webcast found in the Investor Relations section of www.avanir.com. The archive will be available for 30 days following the event.

For more information on the Investor Relations Day please refer to contact information within this press release.

About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

Burns McClellan Contact
Ami Bavishi
abavishi@burnsmc.com
+1 (212) 213-0006

 


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
2. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
3. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
4. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
5. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
6. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
7. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
8. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
9. Avanir Pharmaceuticals to Participate in Two Conferences in August
10. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... PLEASANTON, Calif. , May 23, 2017 /PRNewswire/ ... world,s most innovative medical devices for pressure ulcer ... at the American Association of Critical Care Nurses, ... Houston May 22-25. The Leaf Patient ... designed specifically for the hospital environment.  The system ...
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/18/2017)... 17, 2017  Bayer announced today that the latest ... presented at the 53 rd Annual Meeting of ... June 2-6 in Chicago . ... prostate, colorectal, liver and thyroid cancers, as well as ... II CHRONOS-1 trial of copanlisib in patients with relapsed ...
Breaking Medicine Technology:
(Date:6/26/2017)... , ... June 26, 2017 , ... Torrance dentist, Dr. ... can be one of the most noticeable aspects of a person’s appearance. A healthy, ... everyone is born with beautiful, balanced teeth, everyone can have the smile of their ...
(Date:6/26/2017)... ... 26, 2017 , ... The Centers for Advanced Orthopaedics (The ... Richard Robinson as chief operating officer (COO). In this role, Robinson brings more ... record of simplifying business processes and developing growth strategies to increase market share. ...
(Date:6/26/2017)... ... 26, 2017 , ... LARKR™ , an innovative new smartphone app providing ... the country to join its online treatment platform. , Launching in just a ... substantially greater number of people in need nationwide, and to supplement their traditional practices. ...
(Date:6/26/2017)... ... June 26, 2017 , ... New patients with missing teeth ... or without a referral. Dr. Cotey is a trusted dentist who has placed many ... option. , Patients with missing teeth in Fitchburg, WI, are encouraged to find out ...
(Date:6/25/2017)... ... June 25, 2017 , ... Republicans in the United States Senate ... called the Better Care Reconciliation Act. It differs significantly from the American Health Care ... be reconciled in committee, or the House will have to take up the Senate ...
Breaking Medicine News(10 mins):